Page last updated: 2024-09-05

2-hexynyladenosine-5'-n-ethylcarboxamide and 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine

2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine in 1 studies

Compound Research Comparison

Studies
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Trials
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Recent Studies (post-2010)
(2-hexynyladenosine-5'-n-ethylcarboxamide)
Studies
(8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine)
Trials
(8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine)
Recent Studies (post-2010) (8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine)
2802108014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C1

Other Studies

1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine

ArticleYear
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles

1997